Implementation of the Updated American Veterinary Medical Association Guidelines for the Euthanasia of Animals: 2020 Edition, 10454-10455 [2020-03607]
Download as PDF
<![CDATA[
10454
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
New reviewer .......................................................................
Updating reviewer information .............................................
1,194
7,953
1
1
1194
7953
.166
.333
198
2,648
Total ..............................................................................
9,147
........................
9147
........................
2,846
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–03587 Filed 2–21–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
lotter on DSKBCFDHB2PROD with NOTICES
Number of
responses per
respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
General Medical Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: May 21, 2020.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate for the
discussion of program policies and issues;
opening remarks; report of the Director,
NIGMS; and other business of the Council.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Closed: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Erica L. Brown, Ph.D.,
Acting Associate Director for Extramural
Activities, National Institute of General
Medical Sciences, National Institutes of
Health, Natcher Building, Room 2AN24F,
Bethesda, MD 20892, (301) 594–4499,
erica.brown@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/About/Council, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: February 18, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–03542 Filed 2–21–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Implementation of the Updated
American Veterinary Medical
Association Guidelines for the
Euthanasia of Animals: 2020 Edition
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Institutes of
Health (NIH) is providing guidance to
Public Health Service (PHS) awardee
institutions on implementation of the
American Veterinary Medical
Association (AVMA) Guidelines for the
Euthanasia of Animals: 2020 Edition
(‘‘Guidelines’’). The NIH is seeking
input from the public on any concerns
they may have regarding the updated
Guidelines.
SUMMARY:
Public concerns regarding the
updated AVMA Guidelines for the
Euthanasia of Animals: 2020 Edition
must be submitted electronically at
https://grants.nih.gov/grants/rfi/
rfi.cfm?ID=105 by 11:59:59 p.m. EDT on
April 29, 2020, in order to be
considered.
DATES:
E:\FR\FM\24FEN1.SGM
24FEN1
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
FOR FURTHER INFORMATION CONTACT:
Patricia Brown, Director, Office of
Laboratory Animal Welfare, Office of
Extramural Research, National Institutes
of Health, 6700B Rockledge Drive, Suite
2500, Bethesda, MD 20892–6910,
phone: 301–496–7163, email: olaw@
od.nih.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The NIH Office of Laboratory Animal
Welfare (OLAW) oversees PHS-funded
animal activities by the authority of the
Health Research Extension Act of 1985
and the PHS Policy on Humane Care
and Use of Laboratory Animals (Policy).
The PHS Policy, IV.C.1.g., requires that
Institutional Animal Care and Use
Committees (IACUCs) reviewing PHSconducted or supported research
projects, determine if methods of
euthanasia used in projects will be
consistent with the recommendations of
the AVMA Panel on Euthanasia, unless
a deviation is justified for scientific
reasons in writing by the investigator.
PHS-Assured institutions are
encouraged to begin using the 2020
Guidelines as soon as possible when
reviewing research projects, and full
implementation is expected after
October 1, 2020. Previously approved
projects undergoing continuing review
according to PHS Policy, IV.C.5., which
requires a complete review at least once
every 3 years, must be reviewed using
the 2020 Guidelines after October 1,
2020.
II. Electronic Access
The AVMA has posted the AVMA
Guidelines for the Euthanasia of
Animals: 2020 Edition at https://
www.avma.org/KB/Policies/Documents/
euthanasia.pdf (PDF).
Dated: February 18, 2020.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2020–03607 Filed 2–21–20; 8:45 am]
lotter on DSKBCFDHB2PROD with NOTICES
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Program Evaluation
for Prevention Contract (PEPC)—
Strategic Prevention Framework for
Prescription Drugs (SPF–Rx) Evaluation
(OMB No. 0930–0377)—Revision
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Behavioral Health
Statistics and Quality (CBHSQ) aims to
complete a cross-site evaluation of
SAMHSA’s Strategic Prevention
Framework for Prescription Drugs (SPF–
Rx). SPF–Rx is designed to address
nonmedical use of prescription drugs as
well as opioid overdoses by raising
awareness about the dangers of sharing
medications and by working with
pharmaceutical and medical
communities on the risks of
overprescribing. The SPF–Rx program
aims to promote collaboration between
states/tribes and pharmaceutical and
medical communities to understand the
risks of overprescribing to youth ages
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
10455
12–17 and adults 18 years of age and
older. The program also aims to enhance
capacity for, and access to, Prescription
Drug Monitoring Program (PDMP) data
for prevention purposes. This request
for data collection includes a revision
from previously approved OMB
instruments.
The SPF–Rx program’s indicators of
success are reductions in opioid
overdoses, reduction in prescription
drug misuse and improved use of PDMP
data. Data collected through the tools
described in this statement will be used
for the national cross-site evaluation of
SAMHSA’s SPF–Rx program. This
package covers continued data
collection through 2023. The PEPC team
will systematically collect and maintain
an Annual Implementation Instrument
(AII) and Grantee and Community Level
Outcomes data modules submitted by
SPF–Rx grantees through the online
Data Management System (DMS).
SAMHSA is requesting approval for
data collection for the SPF–Rx cross-site
evaluation with the following
instruments:
Annual Implementation Instrument
(AII)—The AII is a survey instrument
collected yearly to monitor state, tribal
entity, and community-level
performance, and to evaluate the
effectiveness of the SPF–Rx program.
This tool is completed by grantees and
sub-recipient community project
directors, and provides process data
related to funding use and effectiveness,
organizational capacity, collaboration
with community partners, data
infrastructure, planned intervention
targets, intervention implementation,
evaluation, contextual factors, training
and technical assistance (T/TA) needs,
and sustainability.
Grantee- and Community-Level
Outcomes Modules—These modules
collect data on key SPF–Rx program
outcomes, including opioid prescribing
patterns and provider use of PDMP.
Grantees will provide outcomes data at
the grantee level for their state, tribal
area, or jurisdiction, as well as at the
community level for each of their subrecipient communities.
Grantee-Level Interview—This
qualitative interview will be
administered at the end of the
evaluation to obtain information from
the grantee project directors on their
programs, staffing, populations of focus,
infrastructure, capacity, lessons learned,
and collaboration.
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10454-10455]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03607]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Implementation of the Updated American Veterinary Medical
Association Guidelines for the Euthanasia of Animals: 2020 Edition
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institutes of Health (NIH) is providing guidance
to Public Health Service (PHS) awardee institutions on implementation
of the American Veterinary Medical Association (AVMA) Guidelines for
the Euthanasia of Animals: 2020 Edition (``Guidelines''). The NIH is
seeking input from the public on any concerns they may have regarding
the updated Guidelines.
DATES: Public concerns regarding the updated AVMA Guidelines for the
Euthanasia of Animals: 2020 Edition must be submitted electronically at
https://grants.nih.gov/grants/rfi/rfi.cfm?ID=105 by 11:59:59 p.m. EDT
on April 29, 2020, in order to be considered.
[[Page 10455]]
FOR FURTHER INFORMATION CONTACT: Patricia Brown, Director, Office of
Laboratory Animal Welfare, Office of Extramural Research, National
Institutes of Health, 6700B Rockledge Drive, Suite 2500, Bethesda, MD
20892-6910, phone: 301-496-7163, email: [email protected].
SUPPLEMENTARY INFORMATION:
I. Background
The NIH Office of Laboratory Animal Welfare (OLAW) oversees PHS-
funded animal activities by the authority of the Health Research
Extension Act of 1985 and the PHS Policy on Humane Care and Use of
Laboratory Animals (Policy). The PHS Policy, IV.C.1.g., requires that
Institutional Animal Care and Use Committees (IACUCs) reviewing PHS-
conducted or supported research projects, determine if methods of
euthanasia used in projects will be consistent with the recommendations
of the AVMA Panel on Euthanasia, unless a deviation is justified for
scientific reasons in writing by the investigator.
PHS-Assured institutions are encouraged to begin using the 2020
Guidelines as soon as possible when reviewing research projects, and
full implementation is expected after October 1, 2020. Previously
approved projects undergoing continuing review according to PHS Policy,
IV.C.5., which requires a complete review at least once every 3 years,
must be reviewed using the 2020 Guidelines after October 1, 2020.
II. Electronic Access
The AVMA has posted the AVMA Guidelines for the Euthanasia of
Animals: 2020 Edition at https://www.avma.org/KB/Policies/Documents/euthanasia.pdf (PDF).
Dated: February 18, 2020.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2020-03607 Filed 2-21-20; 8:45 am]
BILLING CODE 4140-01-P
